Introducing DefEye

Introducing DefEYE: Biologic innovations that are DefEYEing conventional approaches to ocular surface and ocular surgery. Making their debut this month, DefEYE, formerly operating as Versea Ophthalmics, is a rapidly growing ocular company on a mission to transform and personalize therapeutic approaches in eye care. The company focuses on delivering a portfolio of innovative decellularized biologic solutions that optimize treatment and management of various eye care conditions, including ocular surface diseases, pterygium surgery, and other surgical interventions. To learn more, visit www.defeye.com. Be sure to visit their website and also follow the company on LinkedIn: https://www.linkedin.com/company/defeye/